Treatment using physostigmine of disorientation and agitation caused by dehydrobenzperidol
Pablo, R.; Casas, J.I.; Gil de Bernabé, M.A.; Villar Landeira, J.M.
Revista Espanola de Anestesiologia y Reanimacion 36(5): 297
1989
ISSN/ISBN: 0034-9356 PMID: 2595062 Document Number: 338127
Document emailed within 1 workday
Related Documents
Knapp, S.; Wardlow, M.L.; Albert, K.; Waters, D.; Thal, L.J. 1991: Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjects Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 400-404Donchin, Y.; Ramu, A.; Dudai, M.; Granite, D. 1979: Treatment of dibenzepin poisoning with physostigmine Harefuah 97(7-8): 163-164
Kai-Håkon, C. 1977: Antihistamine poisoning. Treatment with physostigmine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 97(25): 1262-1263
Zoupanos, B.N.; Bryois, C. 2005: Treatment of agitation in the emergency room Revue Medicale Suisse 1(27): 1810-1813
Salzman, C. 1988: Treatment of agitation, anxiety, and depression in dementia Psychopharmacology Bulletin 24(1): 39-42
Regestein, Q.R.; Reich, P. 1985: Agitation observed during treatment with newer hypnotic drugs Journal of Clinical Psychiatry 46(7): 280-283
Glick, R.L.; Ghaemi, S.N. 2000: The emergency treatment of depression complicated by psychosis or agitation Journal of Clinical Psychiatry 61(Suppl 14): 43-48
Brooke, M.M.; Patterson, D.R.; Questad, K.A.; Cardenas, D.; Farrel-Roberts, L. 1992: The treatment of agitation during initial hospitalization after traumatic brain injury Archives of Physical Medicine and Rehabilitation 73(10): 917-921
Azorin, J.M. 1995: Agitation state. Diagnostic orientation and emergency treatment with posology La Revue du Praticien 45(10): 1287-1290
Schaller, J.L.; Burkland, G.A.; Langhoff, P.J. 2007: Do bartonella infections cause agitation, panic disorder, and treatment-resistant depression? Medgenmed: Medscape General Medicine 9(3): 54
Brook, S. 2003: Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia Journal of Clinical Psychiatry 64 Suppl. 19: 13-18
Brandt, T.; Bock, W.J.; Brandt, B.; Viland, B. 1971: Neuroleptic effect of premedication with dehydrobenzperidol Der Anaesthesist 20(6): 215-221
Bascuñana, H.; Villarreal, I.; Alfonso, S.; Terré, R.; Bernabeu, M. 2000: Agitation in head injury. II. Treatment with antidepressant, sympathomimetic, beta blocker , dopaminergic and other drugs Revista de Neurologia 30(11): 1044-1047
Kier, L. 1970: Haldid and Dehydrobenzperidol as adjuvants to local analgesia in carotid arteriography Nordisk Medicin 84(51): 1637-1638
Negri, M.; Borghetto, D.; Perraro, A.; Coppola, L. 1993: Diazepam and dehydrobenzperidol: comparison of 3 protocols of oral premedication in children Minerva Anestesiologica 59(5): 255-259
Romero-Salinas, G.; Pérez-Tamayo, L.; Ruiz-Velasco, V.; Moreno-Martínez, O.; Bravo-Sandoval, J.; Cruz-Montes, G. 1973: Dehydrobenzperidol and its effect on the contractility of the nonpregnant human uterus. Preliminary report Ginecologia Y Obstetricia de Mexico 34(204): 389-396
Salzman, C.; Jeste, D.V.; Meyer, R.E.; Cohen-Mansfield, J.; Cummings, J.; Grossberg, G.T.; Jarvik, L.; Kraemer, H.C.; Lebowitz, B.D.; Maslow, K.; Pollock, B.G.; Raskind, M.; Schultz, S.K.; Wang, P.; Zito, J.M.; Zubenko, G.S. 2008: Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy Journal of Clinical Psychiatry 69(6): 889-898
Nègre, P.; Becret, C. 1999: Temporo-spatial disorientation in the aged Soins. Gerontologie 20: 33-35
Udesen, H.; Madsen, A.L. 1992: Balint's syndrome--visual disorientation Ugeskrift for Laeger 154(21): 1492-1494
Miller, W.F. 2001: The SD/LOC syndrome: spatial disorientation and loss of consciousness Aviation Space and Environmental Medicine 72(3): 321